What is the important safety information for ZEGERID?
The most frequently reported adverse events with ZEGERID are headache, diarrhea, and abdominal pain. In 178 critically ill patients treated with ZEGERID Powder for Oral Suspension, adverse events generally reflected the serious, underlying medical condition of the patients, but some adverse events occurred with more frequency in patients treated with ZEGERID Powder for Oral Suspension than in those treated with the comparator (acid-controlling) drug. For more information about these and other events, please see Table 13 of the Full Prescribing Information. Symptomatic response to therapy does not preclude the presence of gastric malignancy. Atrophic gastritis has been noted occasionally in gastric corpus biopsies from patients treated long term with omeprazole. ZEGERID Capsules contain 304 mg of sodium per dose. ZEGERID Powder for Oral Suspension contains 460 mg of sodium per dose. This should be taken into consideration for patients on a sodium-restricted diet. Sodium bicarbonate is c
Related Questions
- In a URL for CrimeReports.com such as http://www.crimereports.com/?forceCenter=true&lat=45.505806&lng=-122.446364&zoom=13 how do I specify a date range in the URL (not by clicking), for example to specify the last two days ?
- How can you tell if theres a peeping Tom in your neighborhood?
- How are Wexxar packaging machines engineered for safety?
